Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{171327,
        author = {Shivani Dixit and Priyanka Thakur and Shagun and Sakshi Sharma and Akashdeep Singh},
        title = {Novel Antidepressant Agents:  A Review on Mechanism and Biological Targeting Process},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {3859-3864},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=171327},
        abstract = {Depression is a complex and multifactorial disease, and the development of novel antidepressant agents has been a significant challenge. Recently, several novel antidepressant agents have been discovered, offering new hope for the treatment of Depression. This review aims to provide a comprehensive overview of the mechanisms and biological targeting processes of these novel agents. We conducted a systematic review of the literature, including preclinical and clinical studies, to identify the key mechanisms and biological targets involved in the antidepressant activity of these novel agents. Our analysis reveals that these agents target a range of biological processes, including neurotransmitter modulation, neuroinflammation, and neuroplasticity.},
        keywords = {Novel antidepressants, Mechanism of action, Biological targeting, Neurotransmitter modulation, Neuroinflammation, Mono Amine Oxidase Inhibitors.},
        month = {December},
        }